Based on the above results, the high expression of ARF5 is significantly negatively correlated with OS, DFI, PFI and DSS in adrenocortical carcinoma (ACC), brain lower grade glioma (LGG) and liver hepatic carcinoma (LIHC), and LIHC contains more patients (Fig. 2B–. This evidence concerns the gene ARF5 and adrenal cortex carcinoma.